Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Exclusive: Bipartisan letter to Merrick Garland warns of opioid overdose drug shortages
4 years ago
Pharma marketers, take note: Rural patients have technology, but lag in trust and health confidence, study says
4 years ago
Marketing
Wilson's disease treatment from Orphalan gets the go-ahead after PhIII
4 years ago
Manufacturing
Klick Health hires big-name creative talent, adds new style title and working group
4 years ago
People
Marketing
Just weeks after he stepped down as chairman, Emergent's former CEO dies at age 64
4 years ago
People
Manufacturing
AbbVie tosses its triplet therapy for cystic fibrosis, leaving Vertex to reign supreme
4 years ago
FDA approvals, Revlimid LOE and Opdivo's label expansion headline Bristol Myers' start to 2022
4 years ago
Under pressure? FDA pencils in June review dates for Pfizer, Moderna Covid vaccines for kids, plus Novavax EUA
4 years ago
R&D
FDA+
Production halted at Korean pharma after regulators find unauthorized additives in 13 drugs
4 years ago
Manufacturing
Vaccine sales are expected to fade after a Q1 pop at AstraZeneca, but a slate of successful franchises buoys forecast
4 years ago
Changing of the guard: Health marketing agencies Syneos Health and Evoke Kyne promote new female chiefs
4 years ago
Marketing
AstraZeneca unveils plans for R&D center in Kendall Square — which will also be Alexion's new HQ
4 years ago
Gilead’s Covid-19 treatment Veklury props up first quarter gains amid $2.7B Trodelvy writedown
4 years ago
Bristol Myers celebrates a big win with FDA approval of $13B cardio drug mavacamten
4 years ago
R&D
As insulin prices skyrocket, Michigan lawmakers look to make it in-state
4 years ago
Manufacturing
Publicis hosts social health champion Chelsea Clinton on equity, politics and podcasting in healthcare
4 years ago
Marketing
Senators grill Califf over proposed FDA budget as commissioner lays out 2023 priorities
4 years ago
FDA+
Eli Lilly ends Q1 on a high note on the heels of positive obesity trial data
4 years ago
More program cuts ahead as Sanofi CEO Paul Hudson continues to reshape the company
4 years ago
Cannes Lions Health juries announced, pharma and health and wellness awards set for first day gala
4 years ago
Marketing
Big Pharma CEOs assess the BD landscape in biotech: Albert Bourla is staying focused on 2025-2030
4 years ago
Deals
Montreal will be Moderna's next manufacturing venture — report
4 years ago
Manufacturing
Scoop: After failing to secure more funds, a private gene therapy developer lays off staff
4 years ago
People
Cell/Gene Tx
Pfizer can restart PhIII trial of Duchenne gene therapy, now on track for late-2023 FDA approval request
4 years ago
R&D
Cell/Gene Tx
First page
Previous page
204
205
206
207
208
209
210
Next page
Last page